NCT01981395View on ClinicalTrials.gov

Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

April 30, 2016

Conditions
HyperalgesiaAllodynia
Interventions
DRUG

Fenobam

Fenobam 150 mg will be administered and subjects will be monitored for up to 8 hours. During the study day questionnaires will be administered, blood will be drawn a testing site will be marked and pain testing and heat/capsaicin sensitization will be measured.

DRUG

Placebo

A placebo will be administered and subjects will be monitored for up to 8 hours. During the study day questionnaires will be administered, blood will be drawn a testing site will be marked and pain testing and heat/capsaicin sensitization will be measured.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Laura Cavallone

OTHER

NCT01981395 - Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers | Biotech Hunter | Biotech Hunter